Braslyn Ltd., 10% Owner at Mirati Therapeutics, Inc. (MRTX), bought 400,000 shares at $13.00 ($5.2M) on 2017-11-16, disclosed to the SEC on 2017-11-20.
Open-market purchase of $5.2M MRTX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.00 | 144,736 | $1.9M | 36.2% |
| 2 | $13.00 | 255,264 | $3.3M | 63.8% |
| Total | $13.00 avg | 400,000 | $5.2M | 100% |
| Filing → |
| MRTX | SELL | 2020-06-16 | $58.2M | — | Filing → |
| MRTX | SELL | 2019-03-05 | $19.0M | — | Filing → |
| MRTX | BUY | 2017-01-30 | $525K | — | Filing → |